Skip to main content

Full text of "USPTO Patents Application 09230955"

See other formats


This Page Is Inserted by IFW Operations 
and is not a part of the Official Record 

BEST AVAILABLE IMAGES 



Defective images within this document are accurate representations of 
the original documents submitted by the applicant. 

Defects in the images may include (but are not limited to): 



BLACK BORDERS 

TEXT CUT OFF AT TOP, BOTTOM OR SIDES 
FADED TEXT 
ILLEGIBLE TEXT 
SKEWED/SLANTED IMAGES 
COLORED PHOTOS 

BLACK OR VERY BLACK AND WHITE DARK PHOTOS 
GRAY SCALE DOCUMENTS 



IMAGES ARE BEST AVAILABLE COPY. 



As rescanning documents will not correct images, 
please do not report the images to the 
Image Problem Mailbox. 



STIC-I 

From: 
Sent: 
To: 
Subject: 




to. . 



Canella, Karen 

Wednesday, May 14, 2003 3:05 PM 
STIC-ILL 

ill order 09/230,955 



Art Unit 1642 Location 8E12(mail) 

Telephone Number 308-8362 

Application Number 09/230,955 

1 . American Journal of Pathology: 

1993 Feb, 142(2):403-412 
1993, 143(4): 11 50-1 158 
1984, 114(3):454-460 
1996, 148(3):865-875 
1965 Sep, Vol. 44, pp. 280-282 




2. 
3. 
4. 

5. 
6. 

8. 
9. 
10. 
11. 

12. 
13. 
14. 



Cancer Research, 1993 May 15, 53(10 suppl):2287-2299 

Cancer epidemiology, biomarkers and Prevention, 1996 Jul, 5(7):549-557 

Lab Investigation: 

1980. 42(1):91-96 
1988, 58(2):141-149 

Gynecol Oncol, 1 982, 1 3(1 ):58-66 

International Journal of Gynecological Pathology: 
1985,4(4):300-313 
1986, 5(2): 151 -162 
1992, 11(1):24-29 



^ is 




Cancer (Phila), 1989, 63(7): 1337-1 342 
Cancer Res, 1990, 50(16):5143-5152 

Virchows Arch B Cell Pathol Incl Mol Pathol, 1987, 54 (2):98-110 

Acta Histochemica et Cytochemica: 
1994, 27(3):251-257 
1996, 29(1 ):51 -56 

Archives of Gynecology and Obstetrics, 1989, 246(4):233-242 

Clin Lab Med, 1995 Sep, 15(3):727-742 

Clin Obstet Gynaecol, 1984 Apr, 1 1 (1):5-23 




l 



HI Differentiation (1986) 31 : 191-205 



Is and 
inoma 
"nono- 

factor 
arcin- 

[1981) 
rcino- 

ation. 

m for 
3 

An- 
cntia- 
lature 

r-dip- 
i that 

yonal 
ation 

ercn- 
nt of 
pro- 
I Res 

lduc- 
ihibi- 

>n of 
:rmal 

blem 

:iiiTs, 

1985) 
ident 
n re- 
IRcs 

t for 
oma 

ning 
Natl 

The 
cell 

uced 
Is in 

> for 

t 

lion 
403 
duc- 
era- 
MP. 

4ar- 
em- 



86 



Differentiation 

£> Springer-Verlag 1986 



Cytokeratin expression in squamous metaplasia of the 
human uterine cervix 

Orith Gigi-Leitner 1 , Benjamin Geiger 1 *, Rivka Levy 13 , and Bernard Czernobilsky 1 ' 2 

1 Department of Chemical Immunology, The Weizmann Institute of Science Rehovot, Israel 

2 Department of Pathology, Kaplan Hospital, Rehovot, Israel** 

3 Department of Pathology, Tel Aviv University, Tel Aviv, Israel 



Abstract. The expression of cytokeratin polypeptides in 
squamous metaplasia of the human uterine cervix was in- 
vestigated by immunocytochemical labeling with polypep- 
tide-specific antibodies against cytokeratins. Immunofluor- 
escence microscopic examination of cervical tissues using 
various monoclonal antibodies indicated that squamous 
cervical metaplasia expresses a unique set of cytokeratin 
polypeptides, this being distinctively different from that ex- 
pressed by all of the normal epithelial elements of the exo- 
and endocervix. The development of metaplastic foci was 
accompanied by the expression of cytokeratin polypeptide 
no. 13, which is commonly detected in stratified epithelia, 
and by a reduction in the level of polypeptide no. 1 8, which 
is typical of simple epithelia. The 40-kilodalton cytokeratin 
(no. 19) described by Moll etal., which is abundant in the 
columnar and reserve cells of the endocervix, was found 
throughout the metaplastic lesions. Only in ' well-differen- 
tiated' metaplasias did we detect polarity of cytokeratin 
expression reminiscent of the staining patterns in the exo- 
cervix. This was manifested by the exclusive labeling of 
the basal cell layer(s) with antibodies K B 8.37 and K M 4.62, 
which stain the basal cells of the exocervix. Furthermore, 
a comparison of cervical metaplasia with squamous areas 
occurring within endometrial adenocarcinomas pointed to 
a close similarity in the cytokeratin expression of the two. 
We discuss the use of cytokeratins as specific markers of 
squamous differentiation, the relationships between squa- 
mous metaplasia and cervical neoplasia, and the involve- 
ment of reserve cells in the metaplastic process. 



Introduction 

The process of squamous metaplasia involves the transfor- 
mation of differentiated nonsquamous epithelium into 
squamous epithelium [31, 46]. This process is often detected 
in various human tissues such as the bronchi [3, 49], stom- 
ach [9, 32], urinary bladder [25], and salivary glands [11], 
and is especially common in the uterine cervix [12, 13]. 
The human cervix consists of two major areas that are ana- 
tomically and histologically distinct: the exocervix and en- 
docervix. The former is characteristically composed of non- 
keratinizing stratified squamous epithelium, while the latter 



* To whom offprint requests should be sent 
** Affiliated with the Medical School of The Hebrew University 
and Hadassah Hospital, Jerusalem, Israel 



contains a simple epithelial monolayer of columnar cells 
which line the mucosal surface and invaginate into the 
stroma. The sharp squamocolumnar junction detected be- 
tween the two areas is normally located at the cervical por- 
tio [8, 12]. 

This boundary area has been found to be the most com- 
mon site for the development of squamous metaplasia [6, 
12, 43]. This metaplasia is preceded by the outward exten- 
sion of the endocervical mucosa into the exocervical por- 
tion, a process denoting erosion or ectopy [12]. Subse- 
quently, and usually throughout the reproductive period 
of the individual, changes may occur in the ectopic endo- 
cervical mucosa, leading to various degrees of stratification 
of the epithelium and the formation of 'transformation- 
zone metaplasia' (TZM). The metaplastic squamous epithe- 
lium thus formed is usually less ordered than that of the 
neighboring exocervix and can usually be identified by con- 
ventional light microscopy [12]. Nevertheless, is often re- 
tains an apparent continuity with the exocervical epithelial 
layers, and the exact point of transformation is difficult 
to determine (see Fig. 1 c). 

Less frequent, yet still quite common, is the appearance 
of * metaplastic plaques' (MPs) in the endocervical canal, 
which are completely disconnected from any normal squa- 
mous epithelium. These MPs may exhibit variable dimen- 
sions and may differ with regard to the extent of stratifica- 
tion. Similar metaplastic changes may be found not only 
in the normal mucosa but also in malignancies of glandular 
tissues of the female genital tract, including the endocervix, 
forming 'adenocarcinomas with squamous differentiation* 
[26]. 

The factors which induce metaplastic transformation 
are still poorly understood, yet several possibilities have 
been suggested. These include alterations in environmental 
conditions, mechanical irritation, chronic inflammation, 
changes in pH and in hormonal balance, etc. [12, 43]. An- 
other debatable issue concerns the cellular basis of meta- 
plastic transformation : is there a direct ingrowth from the 
native portio epithelium into the transformation zone ([43]; 
or even beyond it), or does the process involve cells of 
purely endocervical origin? Attempts to identify cellular 
precursors for squamous metaplasia exhibiting the latter 
mechanism have focused on two endocervical cell types, 
i.e., * basal* or 'reserve* cells and columnar cells. As will 
be discussed in detail later, the former are commonly scat- 
tered in between the columnar cells of the endocervix and 
confined to the area close to the basement membrane (for 



192 " 

further details, see Discussion). For a number of years, 
these reserve cells have been accepted as being the source 
of cervical squamous metaplasia, a theory originally pro- 
posed by Fluhmann, who called this process "prosoplasia" 
[14]. Until recently, the major, if not only, means of study- 
ing metaplastic transdifferentiation was morphological ob- 
servations using light and electron microscopy. 

Recently, immunocytochemical techniques employing 
cell-type-specific antibodies have been widely used for the 
identification of the histogenetic origins as well as the state 
of differentiation of cells. Particularly useful in this respect 
are specific antibodies reactive with intermediate filament 
(IF) subunits (for reviews, see [17, 36, 37, 41, 51]). It has 
been extensively documented that there are five major, bio- 
chemically and antigenically distinct families of IF subunits 
which are expressed in a cell-type-restricted fashion [2, 28, 
29]. Among those, the cytokeratin family, which is charac- 
teristic of epithelial cells, is further diversified [16, 33, 40]: 
about 20 different cytokeratin polypeptides from various 
human epithelia have been isolated and biochemically, im- 
munochemically, and genetically characterized [18, 23, 33, 
40, 45]. It has further been shown that each type of epitheli- 
al cell contains a characteristic combination of cytokeratin 
polypeptides which may be used to identify that particular 
cell type either in the normal state or after malignant trans- 
formation (for reviews, see [33, 40, 47]). This approach 
has been extensively employed in recent years for the diag- 
nosis of anaplastic tumors and the determination of their 
histogenetic origins [4, 19, 34, 42]. 

In the present study, we investigated the expression of 
specific cytokeratin polypeptides in different forms of squa- 
mous metaplasia of the human cervix. Using both biochem- 
ical and immunohistochemical approaches, we showed that 
cells undergoing metaplastic changes express a unique com- 
bination of cytokeratin polypeptides including the stratifi- 
cation-related cytokeratin polypeptide no. 13 (which is oth- 
erwise absent from the normal mucosa of the endocervix), 
polypeptides nos. 8 and 19, and minute and variable 
amounts of polypeptides nos. 18 and 10/11 (numbers ac- 
cording to the classification of Moll et al. [33]). These re- 
sults suggest that the metaplastic process involves a unique 
step of squamous differentiation of an endocervical cell 
(probably a reserve cell) which is molecularly distinct from 
the process of stratification of the exocervix. The signifi- 
cance of these results and their relevance to cervical neopla- 
sia are discussed. 

Methods 

Tissues 

The cervical tissues studied were obtained from 31 patients 
aged 36-82 years (mean, 54 years) at the Kaplan Hospital, 
whose uteri were removed due to leiomyomas and prolapse. 
The cervix was opened through the external os within 
15 min of hysterectomy, and several sections were obtained 
through the exocervix and endocervix, including the squa- 
mocolumnar junction in a plane parallel to the long axis 
of the cervical canal. The tissues used for immunocytochem- 
ical studies were snap frozen in isopentane that had been 
precooled in liquid nitrogen, and then stored at -70°C. 
For routine histologic examinations, the tissues were fixed 
in 4% buffered formaldehyde, embedded in paraffin [1], 
and stained with hematoxylin and eosin (HE). In 8 out 



of the 31 cases examined, various degrees of cervical squa- 
mous metaplasia were observed, either in continuity with 
the exocervix or in isolated foci within the cervical canal. 

Immunochemical reagents 

The murine monoclonal antibodies used included: 

1. K G 8.13, a broad-spectrum cytokeratin antibody 
which reacts with the cytokeratin filaments present in all 
human epithelial cells tested, i.e., both normal and malig- 
nant cells. This antibody, raised against bovine muzzle kera- 
tin, reacts with a relatively broad range of polypeptides 
including cytokeratins nos. 1, 5, 6, 7, 8, and 18, as well 
as reacting weakly with cytokeratins nos. 10 and 1 1 [22], 

2. K K 8.60, an antibody reactive with human cytokera- 
tin polypeptides nos. 10 and 11. As previously suggested, 
this antibody might be a specific marker of keratinization 
[24]. 

3. K s 8.12, an antibody that reacts with polypeptides 
nos. 13 and 16, which are present in stratified nonkeratiniz- 
ing epithelia as well as in squamous carcinomas [24], 

4. K B 8.37, an antibody which reacts with IFs of cul- 
tured keratinocytes of murine and bovine origin (data not 
shown), as well as with cytokeratin filaments in the basal 
layer of stratified squamous epithelium (skin, exocervix, 
etc. ; see insert in Fig. 2e). This antibody does not react with 
simple, pseudostratified or transitional epithelia in humans. 
The exact polypeptide specificity of this antibody has not 
been defined, since it does not react with electrophoretically 
separated polypeptides of the exocervix in Western-blot 
analysis. The epitope specifically recognized by this anti- 
body may be conformation dependent and thus be irreversi- 
bly destroyed by electrophoretic separation. Regardless of 
its fine molecular specificity, we used antibody K B 8.37 as 
a marker of the basal layer of the squamous epithelium. 

5. K M 4.62, a monoclonal antibody prepared against cy- 
toskeletal polypeptides of cultured human adenocarcinoma 
line MCF-7. This antibody reacts with only one human 
polypeptide, i.e., no. 19 [21]. 

6. K s 18.18, a murine monoclonal antibody which reacts 
with human cytokeratin polypeptide no. 18 and stains sim- 
ple and pseudostratified epithelia as well as the basal layer 
of several noncornifying stratified squamous epithelia 
(W.W. Franke, unpublished data). This antibody was 
kindly supplied by Prof. W.W. Franke (German Cancer 
Research Center, Heidelberg, FRG). 

The different monoclonal antibodies used were usually 
applied as undiluted hybridoma culture supernatants. 

The secondary antibodies were affinity-purified goat an- /■ 
tibodies raised against mouse F(ab') 2 , and conjugated to 
lissamine rhodamine sulfonyl chloride as previously de- 
scribed [5, 20]. 

Immunohistochemistry 

Frozen sections of tissue blocks were cut at about -20° C : V 
in a Frigocut 2700 cryostat (Jung-Reichert, FRG). The sec- '.\ 
tions (4-5 um thick) were placed on clean glass slides, air : j 
dried, acetone fixed, and immunolabeled as previously de- : | 
scribed [15]. Antibody-stained sections were dehydrated in | 
absolute ethanol, mounted in Entelan (Merck, FRG) and : :| 
examined using a Zeiss Photomicroscope III equipped for ^ 
epifluorescence observations with oil-immersion Plan Neo- u 
fluar objectives ( x 25/0.8 or x 16/0.5). 



ft/*/ eli 




jisectedi 
||high-s 
|-atin c< 
I'dimen 
I;:f48]. 
f| 
ii*E!ectr 

fl^Fresh: 
Ifblocki 
i|'hyde i 
'Ip.postfi 
■ence, 
fusing; 
;voltag 



iKesulj 

pThehi 
l^ytaplasj 
lin Fig 



p. of not 



. 0 - : nonst 
|,:|||: 8.60 
§p!. ; . grouj: 

(pig-' 

: regioi 
'M 18,18 
|p:- canth 

fill, mous 

serve* | 

£11 T 
bodie 
v d, res 
| : with 
I and 
I exam 



Material may b# 



Stediby 'cbpynght taw .(Title 17, U.S. Code) 




ibody 
in all 
nalig- 
kera- 
tides, 
: well 
2]. 

kcra- 
:sted, 
ation 

Hides 
tiniz- 

:* cul- 
a not 
basal 
rrvix, 
with 
nans. 
5 not 
cally 
-blot 
anti- 
/ersi- 
ss of 
M as 
n. 

;t ey- 
loma 
iman 

*acts 
sim- 
layer 
helia 
was 
nccr 

aally 

t an- 
d to 
de- 



0°C 
sec- 
, air 

de- 
d in 
and 

for 
Jeo- 



HfjSe/ electrophoresis and immunoblotting analyses 

liiRelevant regions of 20-um-thick frozen sections were dis- 
IltlSected out under microscospic control and extracted with 
||v jiigh-salt buffer and detergent [33]. Analysis of the cytoker- 
f|ll&tin composition in the sections was carried out using one- 
plidimensional gel electrophoresis [27] and immunoblotting 
H[48]. 

m$fc\Ji!ectron microscopy 

; 

Freshly obtained surgical samples were dissected into small 
|||j|>locks (2-3 mm) and immediately fixed in 2% glutaralde- 
^p.; fcyde in 0.1 M cacodylate buffer, pH 7.2. The samples were 
||; j>ostfixed in 1% 0s0 4 , embedded in Poly bed 8.12 (Polysci- 
ISience, USA), cut at the desired orientation, and examined 
||; using a Phillips 410 electron microscope at an accelerating 
Iff voltage of 80 kV. 



Kesults 

|| The histological appearance of the various normal and me- 
Hftaplastic epithelial elements of the human cervix is shown 
"in Fig. 1. 

^Cytokeratin expression in the epithelial elements 
fof normal human cervix 



To establish the pattern of cytokeratin expression as re- 
vealed by immunofluorescence labeling, frozen sections of 
various regions along the cervix were stained with the six 
cytokeratin-specific monoclonal antibodies. 

The normal exocervix, throughout its entire length, had 
an appearance typical of stratified -squamous epithelium, 
with a distinct layer of basal cells and well-ordered supraba- 
sal squamous cells (Fig. 1 a). All epithelial layers of the exo- 
cercix were intensely labeled with the broadly cross-reacting 
K G 8.13 cytokeratin antibody (Fig. 2a) as well as with the 
* stratification-specific ' antibody, K s 8.12 (Fig. 2b). Two of 
the antibodies used, K M 4.62 and K B 8.37, exclusively la- 
beled the basal cell layer (Fig. 2c and e, respectively). It 
should be pointed out, however, that in other squamous 
epithelial tissues, there are marked differences between the 
staining patterns produced by these last two antibodies; 
antibody K M 4.62 stains most simple epithelia but does not 
label keratinizing squamous epithelia (e.g., epidermis), 
while K B 8.37 labels the basel cell layer of keratinizing and 
no n keratinizing squamous epithelia but is negative in all 
nonsquamous epithelia. Staining of the exocervix with K K 
8.60 produced sporadic labeling of individual cells or 
groups of cells within the suprabasal layers of the exocervix 
(Fig. 2f); the extent of this labeling varied somewhat from 
region to region and from sample to sample. Antibody K s 
18.18 (reactive with only polypeptide no. 18 did not signifi- 
cantly or reproducibly stain any component of the squa- 
mous epithelia of the exocervix (Fig. 2d). Occasionally, 
faint staining of the basal cells of the exocervix was ob- 
served (see Fig. 2d insert). 

The normal endocervix was uniformly positive for anti- 
bodies Kg 8.13, K M 4.62, and K 8 18.18 (Fig. 3 a, c, and 
d, respectively). No labeling of the endocervix was obtained 
with the other three antibodies testes, i.e., K s 8.12, K B 8.37 
and K K 8.60 (Fig. 3b, e, and f, respectively). Histological 
examination of HE-stained sections of the endocervix often 



193 



revealed the presence of cuboidal cells within the columnar 
epithelium. These cells were situated near the basal portion 
of the columnar cells and were not exposed at the surface 
of the mucosa (Figs. 1 b and 4 a). These cells, identified as 
being reserve cells, exhibited the same labeling pattern as 
columnar cells with all of the cytokeratin antibodies testes 
(Fig. 4a-f). 

A high-resolution view of these reserve cells of the endo- 
cervix was obtained using transmission electron microsco- 
py. Examination of the endocervical mucosa indicated that 
these cells were cuboidal cells with electron-lucent cyto- 
plasm and a large, round nucleus (Fig. 5a). These cells did 
not reach the luminal surface of the endocervix, nor were 
they directed attached to the basement membrane (Fig. 5 b, 
arrowheads). Examination of a large number of samples 
indicated that the reserve cells were trapped' between the 
columnar cells, and were attached at their basal aspects 
to membrane projections and lamellae of the columnar cells 
(Fig. 5b; see Discussion). 

Reserve cells were usually sparsely distributed along ma- 
jor parts of the endocervix, and the unequivocal identifica- 
tion of individual cells was often difficult. However, we 
occasionally detected endocervical regions in which various 
degrees of reserve-cell hyperplasia were apparent (Fig. 4f, 
arrowheads). This manifested itself by a local accumulation 
of cuboidal cells in one or a few layers, in which the 'nor- 
mal ' columnar cells could be detected at their mucosal as- 
pect (Fig. 4a). Staining of hyperplastic reserve cells with 
the cytokeratin antibodies revealed positive reactivity with 
K c 8.13, K s 18.18, and K M 4.62 (Fig. 4f, arrowheads) as 
in the endocervical mucosa (Fig. 3). No labeling of hyper- 
plastic reserve cells was observed with antibody K s 8.12 
(Fig. 4c) or with antibodies K B 8.37 and K K 8.60 (data 
not shown). 

Cytokeratin expression in squamous metaplasia 
of the human cervix 

We distinguished four types of squamous metaplasia. In 
the first two metaplasia of the TZM in continuity with 
the normal exocervix (type a; Figs. 1 c, e and 6a--e) and me- 
taplasia situated within the endocervical canal and its invag- 
inations at a distance from the MP (type b; Figs. 1 f and 
60, the metaplasia exhibited diminished maturation and 
lacked a definite basal layer when compared to normal exo- 
cervical squamous epithelium (Fig. 1 c). We also found a 
more mature type of metaplasia of the transformation zone, 
with distinct, hyperplastic basal cells occupying more than 
the usual one layer of cells (type c; Fig. 7). Finally, we iden- 
tified metaplasia occurring in glandular elements of an en- 
dometrial carcinosarcoma (type d; Fig. 8). 

Immunofluorescence labeling of metaplasia of the first 
category (type a) with the cytokeratin antibodies resulted 
in the metaplastic cells being extensively labeled with K G 
8.13 (Fig. 6a), K s 8.12 (Fig. 6c), and K M 4.62 (Fig. 6e, f). 
No labeling was obtained with the basal-cell-specific anti- 
body, K B 8.37 (data not shown), and individual positive 
cells were detected throughout the sections after labeling 
with antibody K K 8.60 (Fig. 6d). Staining with antibody 
K„ 18.18 produced essentially no labeling of most of the 
metaplastic cells (Fig. 6 b), although in some cases, faint 
staining of the basal cell layer of the squamous metaplasia 
was noticed. Occasionally, strongly labeled residual endo- 
cervical epithelial cells were detected at the luminal aspect 





Fig. la-f. Light-microscopic appearance of HE-stained sections of normal hyperplastic and metaplastic human cervix The reeions 
examined were near to the squamocolumnar junctions (a, c, e) and in the cndc<*rvical canal (b, d/n a Z juncJon between the 

^m^s^^s^ss? and . the . simplc epi r, ium ° f i be endocervix tss 

area (xzzs). b Endocervix displaying both simple columnar epithelium and a layer of reserve cells (arrowhead- x22S) cSmiammis 
metaplasia at the transformation zone (TZM). The arrow indicates a site of previous biopsy ( x60). iR^T^h^rS^^ZZal 
in the endocery.cal canal; not.ee the apparently normal epithelium at the top (x 150). e Squamous SS^nSSShS^ 
the residual columnar cells ( x 240). f Metaplastic plaques (MP) in the endoce^cal glands &rrZe J x ?$ ' 



' 'M¥teriah^^B^^'6ted :: £y copyright law (Title 1 7, U.S. Code) 




gions ^i'iBiJtll-lFig. 2a-f. Immunofluorescence microscopic labeling of the exocervix with monoclonal antibodies, a K G 8.13; b K s 8.12; c K M 4.62; 

n the K s 18.18; eK B 8-37 (insert in e shows staining of filaments in the basal cell layer at a higher magnification); f K K 8.60. Note 

iction -that antibody K G 8.13 uniformly labeled all of the epithelium, while K s 8.12 stained the suprabasal layers more intensely. K M 4.62 

mous ^ift -and K B 8.37 stained only the basal layer, while antibody 8.60 stained individual cells or groups of cells. Antibody 1^ 18.18 was 

head) xflifSf! essentially negative, except for occasional faint labeling of the basal cells (insert in d). epithelium; 5, stroma. The arrows in b 

icates IP and f point to the basal lamina. Bars, 25 um 








«g.3^f .Immunofluorescence microscopic labeling of frozen sections of endocervical simple epithelium with monoclonal antibodies.: 
aK ° 8 : , . 3; ,. b , Ks „ * n '\ C L K " 4 62 : d K» 18 - 18 ; e K " 8 -3 7 ; f 8.60. Note the positive reaction of K G 8.13, K M 4.62, and K. 18.18 
with epithelial cells, this being in contrast to antibodies K s 8.12, K B 8.37, and K K 8.60 which were negative. S, stroma; E, epithelium; 

L, lumen. Bar, 25 \im K 



''"Matenafinay te proiected by copyright law (Title 17, U.S. Code) 






jpRg. 4a-f. Hematoxylin-eosin staining (a) and immunofluorc 
lather normal or hyperplastic reserve cells, b K G 8.13; c 
|eells (arrowheads) by antibodies K G 8.13, K % 18.18, and K M 

:&V_ ft M A\A nnl 1nlv>l pnithnlial rpllc in th*» pnHfirprviY F. e*n\ 



1 




scence labeling (b-f) with monoclonal antibodies of the endocervix revealing 
ft s 8.12; d K s 18.18; e, f K M 4.62. Note the extensive staining of reserve 
4.62. The double-arrowhead in f indicates reserve cell hyperplasia. Antibody 
. : . : ,:« s »«v .» j ~, - r .thelium; S, stroma; L, lumen. Bar, 25 um 



199 




i. (The;: 
t reach v 
ociated 




il!:>Fig. 6a-f. Immunofluorescence microscopic labeling of cervical squamous metaplasia using different monoclonal antibodies, a K G 8.13; 
||; "b K s 18.18; c K s 8.12; d 8.60; e, f K M 4.62. Note that antibodies K 0 8.13 and K, 8.12 stained the squamous metaplasia uniformly, 
t^Avhile K, 18.18 stained only the residual columnar cells of the simple epithelium of the endocervix. Antibody K K 8.60 labeled individual 
" [cells or groups of cells in the supra basal layers of the metaplasia, and K M 4.62 uniformly stained all cells of the squamous metaplasia, 
|: :both at the transformation zone (e) and in the endocervical canal (f). Note the sharp boundary between the negative suprabasal cells 
| : : : : of the exocervix and the metaplastic cells in e. Ex, exocervix; S, stroma; M> metaplasia. Bars, 25 



1 



? : : M 17; VS. Code) 




Fig. 7a-f. Hematoxylin-eosin staining (a) and immunofluorescence microscopy (b-f) of a transformation zone metaplasia exhibiting 
a high degree of squamous differentiation, b K c 8.13; c K M 4.62; d K s 8.12; e K B 8.37; f K K 8.60. Note that K G 8.13 and Ki? : " M: 
8.12 uniformly stained the squamous metaplasia, while K M 4.62 and K B 8.37 stained predominantly the basal layers. Antibody K K 
8.60 stained individual cells or groups of cells within the suprabasal region. 5, stroma. Bars, 25 jim 




Fig. 8 

||pas the 

li : .- onlv 1 
H£ S t strc 




hibiting : 

and K5.;;; 
o6y Kg:;;; 




i;i Kg. 8a-f. Hematoxylin-cosin (a) and immunofluorescence microscopy (b-f) of a squamous area within an endometrial adenocarcinoma. 
II 1>K G 8.13; c K s 8.12; d K, 18.18; e K M 4.62; f K K 8.60. Note that antibodies K G 8.13 and K M 4.62 stained the metaplasia as well 
If- as the surrounding adenocarcinoma, while K s 8.12 stained only the metaplasia. K K 8.60 stained individual cells in keratinizing foci 
s only in the metaplasia. K s 18.18 stained the metaplasia faintly as compared to its intense labeling of adenocarcinoma cells. Af, metaplasia; 
stroma; Ad, adenocarcinoma. Bars, 25 um 



202- 



CN 

00 
CO 



£0 
O 



o 

CO 
00 



: ■ ; i 




Fig. 9. Immunoblotting analysis of human cervical metaplasia cy- 
tokeratins using antibodies K s 8.12 and K K 8.60. Metaplastic re- 
gions were microdissected and examined by one-dimensional gel 
electrophoresis. The Coomassie-blue (C5)-stained gel contained 
polypeptides in the 57- to 59-kilodalton range (corresponding to 
polypeptides 5 [35J and 10/11; upper dot) as well as in the ~ 54-kilo- 
dalton area (comigrating with polypeptide no. 13; second dot from 
top). The two lower dots mark the position of polypeptides nos. 16 
(48-kilodaltons) and 19 (40-kilodaltons) which are barely detect- 
able by Coomassie-blue staining. The double-arrowhead on the right 
indicates the presence of polypeptides nos. 10 and 1 1 in comparable 
amounts. The reaction with antibody K s 8.12 shows the major 
reactivity of the antibodies with polypeptide no. 13 (upper arrow- 
head). The lower band (lower arrowhead) com i grated with polypep- 
tide no. 16 



Monoclonal Polypeptide 
antibody specificity 



K c 8 * 13 1.5.6.7.8 
(10. 11), 18 



K s 8 • 12 13. 16 



Ex M En 




Ex M g. 




Ex M En 



4 . 62 19 



K B 8 • 37 1 



Kg 8 • 60 10, 11 





Ex M En 



X. 18 • 18 18 



\ 



Fig. 10. Schematic diagram showing the different patterns of stain- 
ing produced by the monoclonal antibodies used in this study. 
The different regions of the cervix, exocervix (Ex\ metaplasia (A*), 
and endocervix (En) are marked, and positive reactivity is indicated 
by the shaded areas. The partial shading of basal cells with antibody 
K, 18.18 represents the faint occasional labeling obtained with this 
antibody. The polypeptide specificities refer to the nomenclature 
of Moll etal. [33,40] 



meti 

§|Immui 
tractcc 
l| ; :atin p< 
lijor gi- 
ll'; spond: 
detect 

In. a; 

Ipand a 
f£4(M6i 
^ analys 
;|£ which 
!;•: and 
fv;: result! 
pi'ly rec 
I'ix.of no 
T body) 
II" to a 
& nos. U 



Discu 



of the metaplasia (Fig. 6 b). Results identical to those ob- 
tained with TZM metaplasia were also obtained with cases 
of MP metaplasia (type b), in which the squamous metapla- 
sia was situated at different sites along the cervical canal 
and its invaginations (data not shown). The information 
obtained from these observations indicated that metaplastic 
cells do not express the same combination of cytokeratin 
polypeptides as any particular cell type of the normal cervix. 
Metaplastic cells were positively labeled with antibody K M 
4.62 but were negative or nearly negative for K 8 18.18, un- 
like the normal mucosa which was positive for both anti- 
bodies. In contrast to the basal layer of the exocervix, the 
metaplastic cells were not labeled with antibody K B 8.37. 
In being uniformly positively labeled with antibody K s 8.12, 
metaplastic cells differed from the columnar and reserve 
cells of the endocervix, both of which were not labeled 
with this antibody (see Discussion). 

Another form of metaplasia (typec) involved a more 



mature type of TZM. This metaplasia retained some order ; 
of layers, contained prominent basal cells, and was general- ■ 
ly similar to the neighboring normal exocervix. It could, ; 
however, be distinguished from the normal exocervix both 
by its anatomical location and by its less ordered strati flea- : 
tion (Fig. 7a). fhe staining patterns of this metaplasia with 
the battery of cytokeratin antibodies used was different 
from that of the 'common 1 forms of metaplasia described 
above (types a and b); while all were positively labeled 
with antibodies K G 8.13 and K s 8.12 (Fig. 7b, d), typec; 
was only partly positive with K M 4.62 (Fig. 6c), and its 
basal cells were positively stained by antibodies K B 8.37 : ; 
(Fig. 6e) and K, 18.18 (not shown). This is in contrast with • 
the common forms of metaplasia which were uniformly pos- j 
itive with antibody K M 4.62, and negative with K B 8.37/ 
Antibody K K 8.60 labeled individual cells throughout the :;| 
metaplasia in all three forms (Fig. 7f). 

Finally, we examined the transformation of malignant 1 



."■ V .iMatesff^^rfffiiK; &i^|j#b@i^#tf Jg^! 'Sdpy ri^ftt .law .0Tttle U.S. Code) . :.; 




203 




En 



En 



Dfstam-; : 
s study^*; 
sia 

idicaU$i; 
ntibod^p 

nclaiurei:; 



e order : 
;enera|r : : 
coul<| • 
ix boflM 
■atifig^ 
;ia with - : 
iffereoti 
scribecj;;;:: 
label^ 

typefl 
and it$| 

LSt wi% : ; 
ily pofe: 
B 8-371 

3Ut tfe|| 



jgpithelia, rather than normal simple epithelia, into stratified 
Isquamous epithelium. Figure 8 a shows a glandular region 
||&ithin a carcinosarcoma of the endometrium exhibiting dis- 
llinct foci of squamous metaplasia. Immunofluorescence la- 
l&eling of this tissue with the cytokeratin-specific antibodies 
flfig. 8b-i) produced exactly the same staining pattern ob- 
tained in the TZM and MP of the endocervix described 
Ipbove. 

immunoblotting analysis of cytokeratin polypeptides present 
|gj metaplastic cervical tissues 

llimmunoblotting analysis of microdissected, high-salt-ex- 
Jlfracted tissue sampes revealed the major groups of cytoker- 
j&jrtin polypeptides present in this metaplastic tissue. The ma- 
imer groups of polypeptides detached were bands corre- 
sponding to polypeptide no. 5, which has previously been 
l<ietected in this tissue [35], as well as to polypeptide no. 10/ 
I'll. A second group was found near polypeptide no. 13, 
fund a few smaller polypeptides with molecular masses of 
lljO-46 kilodaltons were barely detectable. Immunoblotting 
^analysis of this sample was carried out in order to determine 
which of the polypeptides recognized by antibodies K s 8.12 
land K K 8.60 was actually present in the metaplasia. The 
flresults (Fig. 9) showed that antibody K s 8.12 predominant- 
jlly recognized polypeptide no. 13 and only small amounts 
J of no. 16 (both of which react with this particular anti- 
|l body). Antibody K K 8.60, on the other hand, was bound 
| to a polypeptide doublet corresponding to cytokeratins 
|: nos. 10 and 11 (present in essentially equal amounts). 

Discussion 

. The present study focused on a relatively common type 
;|-of 'transdifferentiation' event which occurs in the human 
i: cervix, i.e., the development of squamous metaplasia. The 
f: major tool used for studying the nature of the metaplastic 
|; process was the immunocytochemical and biochemical 
\ identification of the cytokeratin polypeptides expressed by 
•j normal cells of the cervix and their metaplastic derivatives. 
; As pointed out in the Introduction, the expression of cyto- 
h keratins in different epithelia has proved to be a most useful 
I marker both of the histogenetic origin of cells as well as 
f of their state of differentiation [47, 50]. In previous studies 
I carried out in several laboratories, the various cytokeratins 
h expressed in normal and pathological specimens of the hu- 
ll; man female genital tract have been identified [10, 30, 35, 
1: 39]. In accordance with the present findings, these studies 
I: have indicated the widespread occurrence of the 40-kilodal- 
I; ton cytokeratin (no. 19) in the endocervix, metaplastic cells, 
i and the basal layer of the exocervix, as well as the presence 
; of cornifying foci in normal exocervix and in squamous 
; metaplasia. 

In the present study, we applied a battery of monoclonal 
imtibodies with restricted and defined polypeptide specifici- 
ties. Staining of normal and metaplastic cervical tissue with 
these antibodies revealed several interesting features relat- 
|:i ing to the process of squamous differentiation in general 
k and to the formation of squamous cervical metaplasia in 
* particular. 

A striking property of squamous metaplasia was re- 
: vealed by the occurrence of a cytokeratin-polypeptide com- 
f bination which is markedly different from that found in 
j the epithelial components of the normal cervix. This is sche- 



matically illustrated in Fig. 10, which shows the labeling 
patterns obtained in the exocervix, in metaplasia, and in 
the endocervix using our six monoclonal antibodies. The 
marked differences between the metaplastic cells and the 
normal cervical components indicate that, regardless of the 
nature of the cellular precursor of the metaplasia, the pat- 
tern of cytokeratin expression in cells changes during me- 
taplastic transformation. Thus, the metaplastic lesions ex- 
hibit a largely nonpolar expression of cytokeratins, this be- 
ing in contrast to the exocervix; the basal cell layer of the 
exocervix was positively labeled with antibodies K B 8.37 
and K M 4.62, whereas the metaplasia was uniformly nega- 
tive with the former and uniformly positive with the latter 
(Fig. 6e). The only suggestion of a limited degree of differ- 
ential expression of certain keratins in distinct regions of 
the metaplasia was the faint, often barely discernible label- 
ing of its basal cell layer with antibody K 8 18.18 (Fig. 6b), 
and the sporadic labeling with K K 8.60 (Fig. 6d). Compari- 
son of the metaplasia with cells of the normal endocervix 
revealed remarkable differences, the most conspicuous of 
which was the expression in the metaplasia of cytokeratin 
no. 13 and its apparently diminished expression of cytoker- 
atin no. 18, which is abundant in normal endocervical mu- 
cosa. From these findings, we propose that the formation 
of squamous metaplasia represents a new route of differen- 
tiation which differs from those detected in the various epi- 
thelial elements of the normal cervix. The cells which are 
induced to undergo metaplastic squamous differentiation 
probably reside in the endocervix. This hypothesis is based 
on anatomical considerations and was corroborated by the 
results of antibody labeling. Our study of a large number 
of cases indicated that metaplastic lesions with similar mor- 
phologies and identical cytokeratin patterns may develop 
at a distance from the squamocolumnar junction and may 
even be detected within adenocarcinomas, thus excluding 
the possibility that squamous metaplasia may be formed 
by a lateral migration of the exocervix. However, we cannot 
at present exclude the possibility that the latter process is 
responsible for the formation of the 4 mature' squamous 
metaplasia of the transformation zone. This mature form 
of metaplasia may develop either by further differentiation 
of the 'common' form of metaplasia or by displacement 
of the exocervical epithelium. 

Findings for human cervical metaplasia in combination 
with the results presented here suggest that reserve cells 
may be at least bipotent. They may normally terminally 
differentiate into columnar, mucous-secreting cells, but 
under certain circumstances, they may adopt a stratification 
pattern of differentiation and form metaplasia [12, 38]. This 
view is corroborated by the finding of apparently intermedi- 
ate stages in the development of metaplasia, i.e., reserve 
cell hyperplasia (Figs. Id, 40- On the basis of the results 
of antibody labeling and immunoblotting following gel- 
electrophoresis analyses, it is further proposed that, 
throughout the stratification process, new cytokeratins, in- 
cluding polypeptides nos. 5 and 13, small amounts of 
nos. 16 and 17, and finally, nos. 10 and 11, are gradually 
co-expressed. These polypeptides appear in metaplasia 
along with three (nos. 7, 8, and 19) of the four cytokeratins 
initially present in the endocervical mucosa. The expression 
of cytokeratin polypeptide no. 18 decreases during the 
course of the metaplastic process. Interestingly, the paired 
polypeptides, nos. 5 and 13, are co-expressed in metaplastic 
cells; studies in several laboratories have indicated that 



Code) 



204 ' 

A 

there are cytokeratin polypeptides pairs that are commonly 
co-expressed in a differentiation-restricted fashion [50]. The 
positive staining of groups of metaplastic cells by antibody 
K K 8.60 suggests that, following stratification, another step 
towards keratinization may occur, this being manifested 
by the appearance of cytokeratins nos. 10 and 11, which 
are commonly found in keratinizing squamous epithelia (see 
[24, 47, 50]). At least some of these polypeptides (i.e., nos. 5, 
7, 8, 17, 18, and 19) have also been detected using two- 
dimensional gel electrophoresis [35]. However, the use of 
various monoclonal antibodies, particularly K„ 8.12, K K 
8.60, and K M 4.62, revealed unequivocally the presence of 
the stratification-specific polypeptides nos. 13 and 16, poly- 
peptides nos. 10/11, and polypeptide no. 19, respectively. 

Another aspect highlighted by our findings involves the 
relationships between squamous cervical metaplasia and 
neoplastic lesions of the cervix. These will be discussed at 
two levels: first, the capacity of squamous metaplasia to 
transform into a neoplastic lesion, i.e., squamous cell carci- 
noma, and second, the capacity of malignant simple epithe- 
lia (i.e., adenocarcinoma) rather than normal simple epithe- 
lia to undergo squamous differentiation. 

The possibility that squamous metaplasia may consti- 
tute a preneoplastic site which is prone to malignant trans- 
formation is supported by clinical and histopathological 
data [7, 44]. The suggestion of a common origin for squa- 
mous metaplasia and neoplasia is corroborated by the pres- 
ent findings as well as by the results of recent studies con- 
cerning the expression of cytokeratins in squamous cell car- 
cinomas and adenocarcinomas (unpublished results). Most 
prominent in this respect is the positive labeling of both 
lesions with antibody K s 8.12 and their common expression 
of the 40-kilodalton (no. 19) polypeptide [33] which is 
stained by antibody K M 4.62 [21]. This is also in line with 
a previous report of diminished levels of cytokeratin no. 18 
in nonkeratinizing squamous cell carcinoma of the cervix 
[35]. It is thus concluded that metaplasia and neoplasia 
may exhibit a similar pattern of differentiation despite the 
marked difference in their proliferative and invasive proper- 
ties. 

The other aspect, which can only be briefly dealt with 
here, concerns the development of squamous metaplasia 
within adenocarcinoma. The existence of adenocarcinomas 
with regions exhibiting squamous differentiation has been 
well established by conventional histopathology [26]. The 
data presented in our study support the view that such 
metaplastic cells express polypeptides largely similar to 
those of 'con ventionaP squamous metaplasias derived from 
normal, nonneoplastic epithelium. This is mainly shown 
by the persistent expression of cytokeratin no. 19 and the 
positive labeling with antibody K s 8.12. We observed vari- 
able degrees of labeling with antibodies to polypeptide 
no. 18, although we still do not know whether this should 
be attributed to the fact that the tissue of origin studied 
here was derived from the endometrium rather than the 
endocervix or to the fact that is was malignant. This aspect 
is now under investigation. It might, however, be concluded 
that virtually the same changes in cytokeratin expression 
occur during metaplastic transformation regardless of 
whether the epithelium of origin is normal or neoplastic. 

In conclusion, the present study shed light on basic pro- 
cesses of squamous differentiation from its early stages, 
characterized by the hyperplastic growth of reserve cells 
through stratification, to the development of focal keratin- 



izing centers, as well as on the molecular relationships be- 
tween squamous metaplasia and neoplastic transformation 
of the cervix. 

Acknowledgements. We would like to thank W.W. Frankc (German 
Cancer Research Center, Heidelberg) for the generous gift of 
monoclonal antibody it, 18.18. This study was supported in pan 
by a grant from the NCRD-BMFT Israeli-German Joint Project 
Program. J 



References 

1. Altmannsberger M, Osborn M, Schauer A, Weber K (1981) 
Antibodies to different intermediate filament proteins. Cell 
type-specific markers on paraffin-embedded human tissue* 
Lab Invest 45:427-434 

2. Anderton BH (1981) Intermediate filaments: A family of ho* 
mologous structure. J Muscle Res Cell Motil 2:141-166 

3. Auerbach O, Gere JB, Forman JB (1957) Changes in the bron- 
chial epithelium in relation to smoking and cancer or the lune 
N Engl J Med 256:97-104 g * 

4. Battifora H, Sun T-T, Bahu RM, Rao S (1980) The use of 
antikeratin antiserum as a diagnostic tool: Thymoma versus 
lymphoma. Hum Pathol 1 1 : 635-641 

5. Brandtzaeg P (1973) Conjugates of immunoglobulin G with 
different fluorophores. I. Characterization by anionic exchange 
chromatography. Scand J Immunol 2:273-290 

6. Castano-Almendral A, Muller H, Naujoks H, Castano-AImen- 
dral JL (1973) Topographical and histological localization of 
dysplasias, carcinomata in situ, microinvasions and microcar- 
cinomata. Gynecol Oncol 1 : 320-329 

7. Christopherson WM, Healon N, Gray LA Sr (1979) Non-inva- 
sive precursor lesions of adenocarcinoma and mixed adeno- 
squamous carcinoma of the cervix uteri. Cancer 44 : 975-983 

8. Coppleson M (1980) The natural history of premalignanl le- 
sions of the genital tract. A colposcopist's view. Exerpta Med 
Int Congr Ser 51 2 : 304-307 

9. Correa P, Cuello C, Duque E (3970) Carcinoma and intestinal 
metaplasia of the stomach in Colombian migrants. J Natl Can 
Inst 44:297-306 

10. Dixon IS, Margaret AS (1984) Immunofluorescent studies of 
human cervical epithelia in vivo and in vitro using antibodies.: 
against specific keratin components. Mol Biol Med 2 * 37- 51 

11. Eversole LR (1978) Clinical outline or oral pathology: Diagno- 
sis and treatment. Lea and Febiger, Philadelphia, pp 56-57 

12. Ferenczy A (1982) Anatomy and histology of the cervix and , 
cervical intraepithelial neoplasia. In: Blaustcin A (ed) Patholo- ' 
gy of the female genital tract, 2nd edn. Springer, Berlin Heidel- 
berg New York, pp 1 26-1 32 

13. Ferenczy A, Richert RM (1984) Female reproductive system: - 
Dynamics of scan and transmission electron microscopy J Wi- ■'. 
ley and Sons, New York, pp 66-68 

14. Fluhmann CF (1954) Comparative studies of squamous meta- := 
plasia of the cervix, uteri and endometrium. Am J Obstet Gyne- 
col 68: 1447-1463 

15. Franke WW, Appelhans B, Schmid E, Frcudenstein C, Osborn 
M, Weber K (1979) Identification and characterization of epi- 
thelial cells in mammalian tissues by immunofluorescence ^ 
microscopy using antibody to prekeratin. Differentiation 
15:7-25 

16. Franke WW, Schiller DL. Moll R, Winter S, Schmid E, Engel- / 
brecht I (1981) Diversity of cylokeratins-differentiation specific "'■ 
expression of cytokeratin polypeptides in epithelial cells and 
tissues. J Mol Biol 153:933-959 

17. Franke WW, Schmid E, Schiller DL. Winter S, Jarasch ED, % 
Moll R, Denk H, Jackson BW, Illmensee K (1981) Differentia- si 
tion-related patterns of expression of proteins or intermediate- -i; 
sized filaments in tissues and cultured cells. Cold Spring Harbor 
Symp Quant Biol 46:432-453 

18. Fuchs E (1983) Evolution and complexity of the genes encoding 




the ki 

|li9. Gabbi 
muno 
huma 
ogist. 
||0. Gcige 
1 cappii 
|l.Gigi-l 
twecn 
I CelU 
!&2. Gigi 
Schill 
deten 
cross* 
|p3. Hanu 
II cyt 
domaj 
I&4. Huszi 
(1986 
in tht 



1129. 



ifc 30. 



31 



asscn 

Laza: 

grate 

Laza; 

ogen< 

Rev 

Loni 

and 1 

Int J; 

Luge 

108: 

Mini 




205 



ips be- 
m ation : 



je rman 
gift of 
in part ; 



(1981) 
■s. Cell 
tissues; ■ 

of hoB : 



use of ; 
versus i 

j with. ;: 
:hangei; 

Vlmen v 
ion of 

:roear;; : 

i-inva- : : 
ideno* ! V 

983 

int le* ! . 
i Med - 

islinal v 
il Can"*" 



stem: 
J Wi- 



the keratins of human epidermal cells. J Invest Dermatol 
81 :141s-144s 

Gabbiani G, Kapanci Y, Barazzone P, Franke WW (1981) Im- 
munochemical identification of intermediate-sized filaments in 
human neoplastic cells : A diagnostic aid for the surgical pathol- 
ogist. Am J Pathol 104:206-216 
1§0. Geiger B, Singer SJ (1979) Participation of a-actinin in the 
W capping of membrane components. Cell 16:21 3-222 
|||. Gigi-Leitner O, Geiger B (1986) Antigenic interrelationship be- 
tween 40 kilodalton cytokeratin polypeptide and desmoplakins. 
.... Cell Motil and the Cytoskeleton (in press) 
|2 Gigi O, Geiger B, Eshhar Z, Moll R, Schmid E, Winter S, 
|fe Schiller DL, Franke WW (1982) Detection of a cytokeratin 



determinant common to diverse epithelial cells by a broadly 
cross-reacting monoclonal antibody. EM BO J 1 : 1429-1437 
Hanukoglu 1, Fuchs WV (1983) The cDNA sequence of a type- 
II cytoskeletal keratin reveals constant and variable structural 
domains among keratins. Cell 33:915-924 
LHuszar M, Gigi-Leitner O, Moll R, Franke WW, Geiger B 
(1986) Polypeptide-specific monoclonal cytokeratin antibodies 
in the differential diagnosis of squamous carcinomas and ade- 
nocarcinomas. Differentiation (in press) 
il25 Koss L (1975) Tumors of the urinary bladder. Atlas of tumor 
|; : ' pathology, second series, fascicle 11. Armed Forces Institute 
M of Pathology, Washington, pp 103 

|j> 26. Kurman RY, Norris HI (1982) Endometrial neoplasia, hyper- 
plasia and carcinoma. In: Blaustein A (ed) Pathology or the 
;W female genital tract. Springer, Berlin Heidelberg New York, 
"I pp 331-333 

i;27. Laemmli UK (1970) Cleavage of structural proteins during the 
Jf assembly of the head of bacteriophage T4. Nature 227 : 680-^85 
§1*28. Lazarides E (1980) Intermediate filaments as mechanical intc- 
grators of cellular space. Nature 283 : 249-255 
f 29. Lazarides E (1982) Intermediate filaments: A chemically heter- 
ogeneous, developmenially regulated class of proteins. Annu 
Rev Biochcm 51 : 219-250 
11: 30. Loning TH, Kohler CH, Casclitz J, Stegncr HE (1983) Keratin 
and tissue polypeptide antigen profiles of the cervical mucosa. 
Int J Gynecol Pathol 2 : 1 05-1 1 2 
31. Lugo M, Putong PB (1984) Metaplasia. Arch Pathol Lab Med 
108:185-189 

| 32. Ming SC, Goldman H, Freiman DG (1967) Intestinal metapla- 
* :: sia and histogenesis of carcinoma in human stomach: Light 
and electron microscopic study. Cancer 20: 1418-1429 

33. Moll R, Franke WW, Schiller DL, Geiger B, Krcpler R (1982) 
The catalog of human cy tokeratins : Patterns of expression in 
normal epithelia, tumors, and cultured cells. Cell 31 : 1 1-24 

34. Moll R, Krepler R, Franke WW (1983) Complex cytokeratin 
polypeptide patterns observed in certain human carcinomas. 
Differentiation 23:256-269 

35. Moll R, Levy R, Czernobilsky B, Hohlweg-Majert P, Dallen- 
bach-Hellweg D, Franke WW (1983) Cytokeratins of normal 
epithelia and some neoplasms of the female genital tract. Lab 
Invest 49:599 -610 

36. Osborn M (1983) intermediate filaments as histologic markers: 
An overview. J Invest Dermatol 81 : 104s-109s 

37. Osborn M, Altmannsberger M, Debus E, Weber K (1984) Con- 
ventional and monoclonal antibodies to intermediate filament 



proteins in human tumor diagnosis. In : Cancer cells, the trans- 
formed phenotypc, vol 1. Cold Spring Harbor Laboratory, 
New York, pp 191-200 

38. Philipp E (1975) Elektronen-mikroskopische Untersuchungen 
fiber die sogenannten Reservzellen und Zylinderepithel des 
menschlichen Cervix Uteri. Arch Gynecol 218:295-311 

39. Puts JOJG, Moesker O, Kenemans P, Vooijs PG, Ramaekers 
FCS (1985) Expression of cytokeratins in neoplastic epithelial 
lesions of the uterine cervix. Int J Gynecol Pathol (in press) 

40. Quinlan RA, Schiller DL, Hartzfeld M, Achtstatter T, Moll 
R, Jorcano JL, Magin TM, Franke WW (1985) Patterns of 
expression and organization of cytokeratin intermediate fila- 
ments. In: Wang E, Fischman D, Licm RKH, Sun T-T (eds) 
Intermediate filaments. Ann NY Acad Sci 455:282-306 

41. Ramaekers FCS, Puts JJG, Kant A, Moesker O, Jap PHK, 
Vooijs GP (1981) Use of antibodies to intermediate filaments 
in the characterization of human tumors. Cold Spring Harbor 
Symp Quant Biol 46:331-339 

42. Ramaekers FCS, Huysmans A, Moesker O, Kant A, Jap P, 
Herman C, Vooijs P (1983) Monoclonal antibody to keratin 
filaments, specific for glandular epithelia and their tumors. Lab 
Invest 49:353-359 

43. Reagan JW, Fu YS (1983) The uterine cervix. In: Silverberg 
SG (ed) Principles and practice of surgical pathology, vol 2. 
J Wiley and Sons, New York, pp 1223 

44. Richart RM (1973) Cervical intraepithelial neoplasia. In: Som- 
mers SC (ed) Pathology annual. Appleton-Ccntury-Croft, New 
York, pp 301-328 

45. Schiller DL, Franke WW, Geiger B (1982) A subfamily of rela- 
tively large and basic cytokeratin polypeptides as defined by 
peptide mapping is represented by one or several polypeptides 
in epithelial cells. EM BO J 1 :761 769 

46. Stedman's Medical Dictionary (1982) 24th edn. Williams and 
Wilkins, Baltimore, p 864 

47. Sun T-T, Eichner R, Schermer A, Cooper D, Nelson WG, 
Weiss RA (1984) Classification, expression and possible mecha- 
nisms of evolution of mammalian epithelia keratins: A unifying 
model. In: Levine A, Topp W, Vande Woude GF, Watson 
JD (eds) Cancer cells, the transformed phenotype, vol 1. Cold 
Spring Harbor Laboratory, New York, pp 169-176 

48. Towbin H, Staehelin T, Gordon J (1979) Electrophonetic 
transfer of proteins from poiyacrylamide gels to nitrocellulose 
sheets : Procedure and some applications. Proc Natl Acad Sci 
USA 76:4350-4354 

49. Trump BF, McDowell EM, Glavin F (1978) The respiratory 
epithelium. III. Histogenesis of epidermoid metaplasia and car- 
cinoma in situ in the human. J Natl Can Inst 61 : 565-575 

50. Tseng SCG, Jarvinen MJ, Nelson WG, Huang JW, Woodcock- 
Mitchell J, Sun T-T (1982) Correlation of specific keratins with 
different types of epithelial differentiation: Monoclonal anti^ 
body studies. Cell 30:361-372 

51. Vogel AM, Gown AM (1984) Monoclonal antibodies to inter- 
mediate filament proteins : Use in diagnostic surgical pathology. 
In: Shay J (ed) Cell and muscle motility. Plenum, New York 
London, pp 397^02 



Received March 1986 / Accepted in revised form April 19, 1986 



ngel- . 
ecific 
and : 




' = . ■*: .: .' :'1v1aferfa?^ U; US. Code)